PharmTech Europe at CPhI - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PharmTech Europe at CPhI

On October 9˜11, 2012, more than 29000 people from over 140 countries are expected to gather at the Feria de Madrid in Spain for CPhI Worldwide 2012 to network, discuss industry trends and hopefully forge new partnerships. This will mark the 23rd edition of this prestigious industry event.

This year, the majority of the PTE team will be attending the show in Mandrid at booth 10A23. You are more than welcome to visit us to let us know what's happening in your corner of the market, or to tell us about something exciting you've seen.

We will be active online during the show, providing daily blogs and feeding important news through our twitter account. If you're not already a follower, and especially if you're not able to attend the show but want to be kept up-to-date, then head to http://PharmTech.com/twitter to join us.

To receive our special CPhI eshow daily and our regular e-newsletter, subscribe here.

CPhI news

What do You Think of CPhI so Far?

Great Expectations for CPhI Worldwide 2012

Start your CPhI Experience with Pre-Connect

Get to Know Madrid

CPhI Worldwide 2012 and Pharma Awards

Sharing Great Innovations at CPhI

Breaking Visitor Records Year on Year

CPhI Takes Centre Stage in Madrid

Strategies for Effective Biologics Outsourcing Examined at CPhI

CPhI Pharma Awards Finalists Announced

CPhI Prepares for India

Changing Industry Models at Work at CPhI

Start your CPhI Experience with Pre-Connect

Useful information

Visitor Registration

Plan Your Stay

Pre-Conference Information

Event Website

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
15%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Click here